|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas:resuhs of a phase II study显示文摘 | Jerman M Jost LM Taverna CH | 2004 | Ann Oncol2004，15，3： | 1 |
| 2 | Rituximab-EPOCH,an effective salvage therapy for relapsed,refractory or trans-formed B-cell lymphomas:results of a phase II study显示文摘 | Jermann M Jost LM Tavema CH | | 0，，03： | 1 |
| 3 | Differentiating Primary Central Nervous System Lymphoma from Glioma in Humans Using Localised Proton Magnetic Resonance Spectroscopy显示文摘 | Harting I Hartmann LM Jost G | 2003 | Neurosci Lett2003，342，3： | 1 |
| 4 | Autonomic nervous system dysfunction in lightning and electrical injuries 显示文摘 | Jost WH Schonroek LM Cherington M | 2005 | Neuro Rehabilitation2005，20，1： | 1 |
| 5 | Randmized study ercombinan human granulocyto colony-stimukating factor ter high-risk ymphoid malignancies显示文摘 | Stahel FA Jost LM Cetuy T | 1991 | J Clin Onco11991，9，： | 1 |
| 6 | A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission 显示文摘 | Stahel RA Jost LM Kroner T Dommann Scherrer C Maurer R Glanzmann C Jacky E Pichert G Pestalozzi B Marincek B Sauter C Honegger H | 1999 | Br J Haematol1999，104，4： | 1 |
| 7 | ESMO minimum clini- cal recommendations for diagnosis, treatment and follow-up of gas- tric cancer显示文摘 | Cunningham D Jost LM Purkalne G | 2005 | Ann Onco12005，16，1： | 1 |
| 8 | Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study显示文摘 | Jermann M Jost LM Taverna CH | 2004 | Ann Oncol2004，15，3： | 1 |
| 9 | Randomized study of recombinant human granulocyte colony stimulating factor after high-dose chemotherapy and autologus bone marrow transplantation for high risk lymphoid malignancies显示文摘 | Stahel RA Jost LM Germy T | 1994 | J Clin Oncol1994，12，： | 1 |
| 10 | Rituximab-EPOCH,an effective salvage therapy for relapsed,refractory or transformed B cell lymphomas:results of a phase Ⅱ study显示文摘 | Jermann M Jost LM Tavena Ch et a1 | 2004 | Ann Oncol2004，15，3： | 1 |
| 11 | Rituximab-EPOCH,an effective salvage therapy for relapsed ,refractory or transformed B-cell lymphomas:results of a phase Ⅱ study显示文摘 | JERMANN M JOST LM TACERNA CH | 2004 | Ann Oncol2004，15，3： | 1 |
| 12 | Rituximab-EPOCH,an effective salvage therapy for relapsed,refractory or transformed B- cell lymphomas: results of a phase Ⅱ study 显示文摘 | Jermann M Jost LM Taverna Ch | 2004 | Ann Oncol2004，15，3： | 1 |
| 13 | Rituximab - EP- OCH, an effective salvage therapy for relapsed, refractory or transformed B -cell lymphomas:resuhs of a phase II study 显示文摘 | Jermann M Jost LM Tavema CH | 2004 | Ann Oncol2004，15，3： | 1 |
| 14 | Rituximab EPOCH,an effective salvage therapy for relapsed,refractory or transformed B-cell lymphomas:resualts of a phase Ⅱ study显示文摘 | Jermann M Jost LM Taverna CH | | 0，，： | 1 |
| 15 | Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autotogous bone marrow transplantation for high-risk lymphoid malignancies显示文摘 | Jost LM CernyT | 1994 | J Clin Oncol1994，12，： | 1 |
| 16 | ESMO Minimum Clinical Recommendations for diagnosis,treatment and follow-up of gasric cancer显示文摘 | Cunningham D Jost LM Purkalne G | | 0，，1： | 1 |
| 17 | Rituximab- EPOCH, an effective salvage therapy for relapsed, refractory or transformed Bs-cell Iymphomas , results of a phase II study显示文摘 | Jermamn M Jost LM Taverna CH et a1 | 2004 | Ann Oncol2004，15，3： | 1 |
| 18 | Rituximab-EPOCH,an effective salvage therapy for relapsed,refractory or transformed B-cell lymphomas:results of a phase Ⅱ study显示文摘 | Jermann M Jost LM Tavema CH | 2004 | Ann Oncol2004，15，3： | 1 |
| 19 | Rituximab-EPOCH, an effec- tive salvage therapy for relapsed, refractory or transformed B-cell lymphomas:results of a phaseⅡ study 显示文摘 | Jermann M Jost LM Tavema CH | 2004 | Ann Oncol2004，15，3： | 1 |
| 20 | Rituximab-EPOCH,an effective salvage therapy for relapsed,refractory or transformed B-cell lymphomas:results of a phase Ⅱ study显示文摘 | Jermann M Jost LM Taverna C | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员